首页> 美国卫生研究院文献>Journal of Nanobiotechnology >Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy
【2h】

Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy

机译:抗ICAM-1抗体修饰的纳米结构脂质载体:肺血管内皮靶向装置用于急性肺损伤治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAcute lung injury (ALI) is a life-threatening clinical syndrome without effective treatment. Targeting delivery of glucocorticoid to lung shows potential efficacy for ALI based on their anti-inflammatory and anti-fibrotic properties, breaking through their clinical application limitation due to systemic side effects. This work was aimed to establish lung-targeted dexamethasone (DEX) loaded nanostructured lipid carriers (NLCs) with opposite surface charge and investigate their therapeutic effects on lipopolysaccharide (LPS)-induced ALI mice.
机译:背景急性肺损伤(ALI)是没有有效治疗方法的威胁生命的临床综合征。根据糖皮质激素的抗炎和抗纤维化特性,将糖皮质激素靶向肺部具有潜在的疗效,由于全身性副作用,突破了其临床应用限制。这项工作旨在建立具有肺表面靶向电荷的地塞米松(DEX)负载的纳米结构脂质载体(NLC),并研究它们对脂多糖(LPS)诱导的ALI小鼠的治疗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号